Engineers Gate Manager’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,193
Closed -$29K 2142
2025
Q3
$29K Buy
+1,193
New +$19.9K ﹤0.01% 2090
2022
Q4
Sell
-8,174
Closed -$768K 1705
2022
Q3
$768K Buy
8,174
+2,943
+56% +$419K 0.05% 560
2022
Q2
$1.17M Buy
+5,231
New +$1.75M 0.04% 601
2021
Q2
Sell
-370
Closed -$406K 1651
2021
Q1
$406K Buy
+370
New +$489K 0.02% 1124
2020
Q1
Sell
-4,241
Closed -$2.67M 1598
2019
Q4
$2.67M Buy
4,241
+2,665
+169% +$1.3M 0.12% 251
2019
Q3
$528K Buy
+1,576
New +$505K 0.03% 754

Other funds holding CDLX

Engineers Gate Manager's CDLX Position: Q4 2025 in Review

Engineers Gate Manager sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 1,193 shares — an estimated $29K sold.

Engineers Gate Manager first reported a position in CDLX in Q3 2019 and held it in 6 quarters. The position peaked at $2.67M in Q4 2019. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • Engineers Gate Manager reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 1,193 Cardlytics shares in Q4 2025, an estimated $29K.
  • Engineers Gate Manager first reported a position in Cardlytics in Q3 2019 and held it in 6 quarters.
  • Engineers Gate Manager's Cardlytics position peaked at $2.67M in Q4 2019.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on Engineers Gate Manager's 13F filing for Q4 2025, filed 17 Feb 2026.